| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 11/07/2001 | EP1150702A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
| 11/07/2001 | EP1150699A1 Treatment of bladder and gastrointestinal mastocytosis |
| 11/07/2001 | EP1150691A2 Novel antisense inhibition of rad51 |
| 11/07/2001 | EP1150690A1 Chemical compounds |
| 11/07/2001 | EP1150689A1 Chemical compounds |
| 11/07/2001 | EP1150677A1 New pharmaceutical formulation |
| 11/07/2001 | EP1150676A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 11/07/2001 | EP1150675A1 A transdermal composition of an antivomiting agent and a preparation containing the same |
| 11/07/2001 | EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease |
| 11/07/2001 | EP1150665A2 Use of statins for treating viral infections |
| 11/07/2001 | EP1150664A2 Novel use of orexin receptor antagonists |
| 11/07/2001 | EP1150661A2 Topical sprays comprising a film forming composition |
| 11/07/2001 | EP1150577A1 Improved microbial preparations |
| 11/07/2001 | EP1150564A1 Inositol derivatives for inhibiting superoxide anion production |
| 11/07/2001 | EP0975380B1 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 11/07/2001 | EP0861235B1 Substituted benzylaminopiperidine compounds |
| 11/07/2001 | EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 11/07/2001 | EP0731705B1 Use of dimeticone for treating constipation |
| 11/07/2001 | EP0546108B1 Pro-drugs for cck antagonists |
| 11/07/2001 | CN1321151A Chemical compounds |
| 11/07/2001 | CN1321150A Amide derivs. useful as inhibitors of production of cytokines |
| 11/07/2001 | CN1321089A Methods and compositions for increasing intestinal absorption of fats |
| 11/07/2001 | CN1321080A Fast dissolving orally consumable films |
| 11/07/2001 | CN1320455A Capsule for treating gastroptosis |
| 11/07/2001 | CN1320450A Medicinal pill for clearing liver heat away, detoxication and diuresis |
| 11/07/2001 | CN1320441A Medicine containing active components of Panax japonicum root and preparing process thereof |
| 11/07/2001 | CN1320427A Composite melatonin and its preparing process |
| 11/07/2001 | CN1320425A Medicine for treating oral ulcer and its preparing process |
| 11/07/2001 | CN1074422C Method for preparing HCV epitope-contg. separated polypeptide |
| 11/07/2001 | CN1074285C Chinese medicine for curing appendicitis |
| 11/07/2001 | CN1074283C Gastric medicine and its preparation method |
| 11/06/2001 | US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 11/06/2001 | US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants |
| 11/06/2001 | US6313270 DbpB |
| 11/06/2001 | US6313189 Polymerizing formulation comprising ethylene glycol or glycero-oligoester (meth)acrylate contained in a porous matrix in the form of the shaped article by means of electromagnetic radiation |
| 11/06/2001 | US6313174 Aminobenzophenones as inhibitors of interleukin and TNF |
| 11/06/2001 | US6313171 Method for preventing or treating elevated blood lipid level-related diseases by administering cinnamic acid derivatives |
| 11/06/2001 | US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors |
| 11/06/2001 | US6313144 For therapy of gastro-esophageal reflux disease, emesis, dyspepsia |
| 11/06/2001 | US6313137 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 11/06/2001 | US6313136 For therapy and prophylaxis of gastrointestinal inflammatory diseases |
| 11/06/2001 | US6313117 Succinate derivative compounds useful as cysteine protease inhibitors |
| 11/06/2001 | US6313116 Phosphodiesterase inhibitors |
| 11/06/2001 | US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 11/06/2001 | US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses |
| 11/06/2001 | US6312730 Gum acacia, mixing powdered psyllium husks and drying |
| 11/06/2001 | US6312723 Compounds used in inhibiting gastric acid secretion 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole in tablet or capsule form with cyclodextrin |
| 11/06/2001 | US6312712 Benzimidazole and cyclodextrin for gastric acid related diseases |
| 11/06/2001 | CA1341317C Water/paraffinic hydrocarbons emulsion enhanced with lecithin extracts and process for making same |
| 11/03/2001 | CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 11/01/2001 | WO2001081590A2 Protein phosphatases |
| 11/01/2001 | WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec) |
| 11/01/2001 | WO2001081582A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 11/01/2001 | WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 11/01/2001 | WO2001081549A2 Hepatocyte lineage cells derived from pluripotent stem cells |
| 11/01/2001 | WO2001081540A2 Growth factor which acts through erb b-4 rtk |
| 11/01/2001 | WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 11/01/2001 | WO2001081404A2 INDUCIBLE PLASMID VECTOR ENCODING TGF-β AND USES THEREOF |
| 11/01/2001 | WO2001081363A1 Novel compounds |
| 11/01/2001 | WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 11/01/2001 | WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 11/01/2001 | WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 11/01/2001 | WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme |
| 11/01/2001 | WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 11/01/2001 | WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators |
| 11/01/2001 | WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 11/01/2001 | WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 11/01/2001 | WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 11/01/2001 | WO2001081310A1 1-aroyl-piperidinyl benzamidines |
| 11/01/2001 | WO2001081298A2 Cyclic carboxylic acids as integrin antagonists |
| 11/01/2001 | WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity |
| 11/01/2001 | WO2001080893A1 Medicinal compositions promoting bowel movement |
| 11/01/2001 | WO2001080878A1 Use of recombinant gastric lipase for treating functional dyspepsia |
| 11/01/2001 | WO2001080877A1 Preventives for reinfection after liver transplantation |
| 11/01/2001 | WO2001080852A1 Compositions and therapies for hyperlipidaemia-associated disorders |
| 11/01/2001 | WO2001080836A1 Use of particulate vectors in immunomodulation |
| 11/01/2001 | WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients |
| 11/01/2001 | WO2001080817A1 Dextranase-containing oral care compositions |
| 11/01/2001 | WO2001080632A1 Cell and nonhuman animal capable of amplifying hcv |
| 11/01/2001 | WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 11/01/2001 | WO2001056573A8 Use of cox-2 inhibitors as gastroprokinetics |
| 11/01/2001 | WO2001042263A3 Oligosaccharide mixture |
| 11/01/2001 | WO2001041762A3 Valdecoxib compositions |
| 11/01/2001 | WO2001041761A3 Valdecoxib compositions |
| 11/01/2001 | WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 11/01/2001 | WO2001036641A3 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 11/01/2001 | WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 11/01/2001 | WO2001030329A3 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infuction |
| 11/01/2001 | WO2001029066A3 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 11/01/2001 | WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 11/01/2001 | WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines |
| 11/01/2001 | WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use |
| 11/01/2001 | WO2001012233A3 Sustained release formulation of a peptide |
| 11/01/2001 | US20010036950 Potassium channel openers |
| 11/01/2001 | US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 11/01/2001 | US20010036941 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders |
| 11/01/2001 | US20010036936 Compositions and methods for treating osteoporosis |
| 11/01/2001 | US20010036635 Cancer screening |
| 11/01/2001 | US20010036500 For enriching foods or beverages, anemia treatment |
| 11/01/2001 | US20010036454 Transfection of lung tissue |